Plant pathogens are extremely variable, presenting a significant challenge in terms of their management with bacteriophage, given their extreme specificity. APS’ patented Biolyse® technology creates unique combinations of bacteriophage, both broad-range and highly specific that effectively address this pathogen diversity, in addition to providing an insurance policy against the development of resistance within the pathogen population.

Formulation options include:

The Biolyse® technology is applicable to any bacterial pathogen/contaminant situation, be it plant- animal- or human pathogens. If you interested in finding out more or in collaborating with APS on a specific project, please contact us.